Elucidation of the molecular mechanism demonstrated that miR-506 promotes G1/S phase arrest, apoptosis and the chemosensitivity of human cervical cancer cells by directly targeting Gli3, revealing that the miR-506/Gli3 axis is a new potential therapeutic drug target for the clinical therapy of human cervical cancer58. This evidence concerns the gene GLI3 and cervical cancer.